Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116396204A reveals a safe, scalable isatin-based route for 4,6,7-trifluoro-1H-indole-2-carboxylic acid, replacing explosive azide chemistry with high-purity outcomes.
Novel synthesis method for Bortezomib intermediates ensures high purity and cost efficiency. Reliable supply chain for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Patent CN101602713B reveals a novel alkaline hydrolysis route for 2-chloronicotinic acid, offering 93% yield and significant cost reduction in agrochemical intermediate manufacturing.
Patent CN112159380B discloses a safe, low-temperature route for Barosavir intermediates, eliminating toxic reagents and enabling cost reduction in API manufacturing.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN113105329B details a palladium-free synthesis route for estrogen antagonist intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108586397A details a mild base-catalyzed route for tetronic acid. Achieve cost reduction in pharmaceutical intermediate manufacturing with high-purity outputs.
Novel water/ethanol synthesis of 5-(aryl methylene) Michaelis acid. High yield, eco-friendly, scalable process for pharmaceutical intermediates.
Novel salicylic acid route for high-purity pharma intermediate. Cost-effective, scalable, low pollution manufacturing solution for global supply chains.
Novel chiral resolution method for captopril intermediate ensures high purity and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Patent CN102898307B offers a mild synthesis route for methyl 4-chlorobutyrate. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN100473642C details a 4-step asymmetric synthesis of alpha-alkyl-isoserine with 98% ee. Offers cost-effective routes for pharmaceutical intermediates.
Novel Lewis acid catalyzed synthesis offers high purity trans-isomer selectivity for pharmaceutical intermediate manufacturing supply chains and significant cost efficiency.
Patent CN116082181B reveals a cost-effective synthesis route for Alzheimer's intermediates. Achieve high purity without column purification for scalable supply.
Patent CN111362807B details a green aerobic oxidation route for 3-nitro-2-methylbenzoic acid, offering high purity and reduced waste for pharmaceutical supply chains.
Patent CN110903182A reveals a cost-effective Friedel-Crafts route for 4-fluoro-2-methylbenzoic acid, offering significant supply chain advantages.
Patent CN116396201A details a safe, scalable DeoxoFluor route for (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid, offering significant cost and safety advantages over traditional DAST methods.
Novel one-step synthesis patent CN103319335B offers high purity greater than 99 percent. Reduces equipment investment and enables green manufacturing for pharmaceutical intermediates.